课题基金 / 基金详情

PRODUCTION OF HYBRIDOMAS

PRODUCTION OF HYBRIDOMAS
杂交瘤的生产
批准号：
2572311
负责人：
R SIRAGANIAN
金额：
$0.0万
依托单位：
NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/2572311
关键词：
antibody receptor antibody specificity antireceptor antibody biological signal transduction hybridomas immunoglobulin E monoclonal antibody phosphoproteins tissue /cell culture

项目摘要

项目成果

R SIRAGANIAN的其他基金

相似基金

相关文献

中文摘要
翻译
正在产生的杂交瘤可以分泌抗病毒的单抗 明确的抗原特异性。在过去，杂交瘤是 选择识别高亲和力IgE受体的人，其 参与的成分和相关的细胞表面蛋白 信号转导。抗其他几种细胞的单抗 表面蛋白也已被挑选出来。在过去一年中 产生了识别磷酸化的单抗。 蛋白质。
英文摘要
Hybridomas are being produced which secrete monoclonal antibodies to defined antigen specificity. In the past hybridomas have been selected that recognize the high affinity IgE receptor, its components and associated cell surface proteins that are involved in signal transduction. Monoclonal antibodies to several other cell surface proteins have also been selected. During the last year monoclonal antibodies were produced that recognize phosphorylated proteins.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PRODUCTION OF HYBRIDOMAS
PRODUCTION OF HYBRIDOMAS
PRODUCTION OF HYBRIDOMAS
MECHANISMS OF HISTAMINE RELEASE
海外基金